WA treatment significantly reduced tumor burden (Fig. 2B-E) and decreased cytokeratin 19-positive (CK19+) malignant cells, alongside diminished lipid droplet accumulation (Fig. 2F-G). This evidence concerns the gene KRT19 and neoplasm.